CYP2D6 and the severity of suicide attempts

被引:0
|
作者
Penas-Lledo, Eva M. [1 ]
Blasco-Fontecilla, Hilario [2 ,3 ]
Dorado, Pedro [1 ]
Vaquero-Lorenzo, Concepcion [2 ,4 ]
Baca-Garcia, Enrique [2 ,3 ,5 ]
Llerena, Adrian [1 ,3 ,6 ]
机构
[1] Extremadura Univ Hosp & Med Sch, Clin Res Ctr, CICAB, Badajoz, Spain
[2] Univ Autonoma Madrid, Dept Psychiat, Fdn Jimenez Diaz Hosp, Madrid, Spain
[3] CIBERSAM, Madrid, Spain
[4] Univ Autonoma Madrid, Dept Biol, Fac Sci, Madrid, Spain
[5] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA
[6] Univ Beira Interior, CIS Fac Ciencias Saude, Covilha, Portugal
关键词
CYP2D6; severity of suicide attempt; ultrarapid metabolizer;
D O I
10.2217/PGS.11.146
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: Among people who die by suicide, an increased frequency of CYP2D6 active gene multiplication has been described. Therefore, the present study analyzed the relationship between the severity of the suicidal intent and CYP2D6 number of active genes among survivors. Materials & methods: A group of 342 individuals were evaluated with Beck Suicide Intent Scale within 24 h of the failed attempt. 'Severe' suicide attempters were classified as those scoring above percentile 75 in the objective circumstances section of the Suicide Intent Scale Scale. A group of 377 healthy controls were also genotyped. Results: A higher number of 'severe' suicide attempters carrying >= 2 active CYP2D6 genes as compared with the rest of the patients population (p < 0.01) or the healthy control group (p < 0.01) was found. Conclusion: Considering that 'severe' suicide attempters are more likely eventually to die by suicide, CYP2D6 genetic polymorphism might be of use as a biomarker of death by suicide, which is in agreement with previous findings. Original submitted: 17 July 2011; Revision submitted: 21 September 2011
引用
收藏
页码:179 / 184
页数:6
相关论文
共 50 条
  • [1] CYP2D6, serotonin and suicide
    Ahlner, Johan
    Zackrisson, Anna-Lena
    Lindblom, Bertil
    Bertilsson, Leif
    [J]. PHARMACOGENOMICS, 2010, 11 (07) : 903 - 905
  • [2] CYP2D6 and Hormones: Implications for Suicide
    Lopez-Castroman, Jorge
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 153S - 153S
  • [3] CYP2D6 and Personality: Implications for Suicide
    Blasco-Fontecilla, Hilario
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 62S - 62S
  • [4] Epigenetic and transcriptional changes in the CYP2D6 gene are related to severity of suicide attempt
    Jokinen, Jussi
    Bostrom, Adrian Emmanuel
    Asberg, Marie
    Schioth, Helgi
    [J]. PSYCHONEUROENDOCRINOLOGY, 2020, 119 : S7 - S7
  • [5] Epigenetic and Transcriptional Changes in the CYP2D6 Gene are Related to Severity of Suicide Attempt
    Jokinen, Jussi
    Bostrom, Adrian
    Asberg, Marie
    Schioth, Helgi
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S156 - S156
  • [6] Severity of Suicide Attempt is Associated With Epigenetic and Transcriptional Changes in the CYP2D6 Gene
    Jokinen, Jussi
    Bostrom, Adrian
    Asberg, Marie
    Schioth, Helgi
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S373 - S374
  • [7] CYP2D6, serotonin, and suicide-a relationship?
    Bertilsson, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 304 - 305
  • [8] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [9] High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders
    Penas-LLedo, E. M.
    Dorado, P.
    Agueera, Z.
    Gratacos, M.
    Estivill, X.
    Fernandez-Aranda, F.
    LLerena, A.
    [J]. MOLECULAR PSYCHIATRY, 2011, 16 (07) : 691 - 692
  • [10] CYP2D6 Polymorphism in Suicide Cases - Preliminary Results
    Riccardi, L. N.
    Lanzellotto, R.
    Ceccardi, S.
    Bini, C.
    Fersini, F.
    Govi, A.
    Mazzotti, M. C.
    Ingravallo, F.
    Pelotti, S.
    [J]. IALM 2012: PRESENTATIONS FROM THE 22ND CONGRESS OF THE INTERNATIONAL ACADEMY OF LEGAL MEDICINE, 2013, : 231 - 234